We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Potential Therapy for Inflammatory Diseases

By Biotechdaily staff writers
Posted on 25 Jul 2002
A new drug target has been discovered for the potential treatment of inflammatory diseases such as rheumatoid arthritis.

The drug target, called DT0221, is a G protein-coupled receptor (GPCR) of the chemokine subfamily and is expressed on a number of leukocyte subsets, including those that serve as effector cells in inflammatory responses. More...
Experimental studies indicate that antagonism of DT0221, as modeled in knockout mice, may treat inflammatory diseases such as rheumatoid arthritis. In this model, mice were challenged with monoclonal antibodies against type II collagen, a challenge known to induce an inflammatory response. Control mice showed a severe inflammatory response in the joints as well as bone and cartilage destruction. In contrast, female mice, in which the gene responsible for DT0221 was knocked out, were completely resistant to joint inflammation induced by the antibody challenge.

The drug target was discovered by scientists at Deltagen, Inc. (Redwood City, CA, USA), a biopharmaceutical company focused on in vivo mammalian gene function information. Deltagen has drug discovery programs in oncology, metabolic disorders, and inflammatory diseases.

"Using our systems biology approach, we believe we have identified a novel target that has potential clinical applications in a variety of important inflammatory diseases, including rheumatoid arthritis,” said Mark Moore, Ph.D., chief scientific officer at Deltagen.




Related Links:
Deltagen

Gold Member
Hematology Analyzer
Medonic M32B
POC Helicobacter Pylori Test Kit
Hepy Urease Test
CBM Analyzer
Complete Blood Morphology (CBM) Analyzer
Capillary Blood Collection Tube
IMPROMINI M3
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Industry experts gather at WHX Labs Dubai to discuss how leadership must adapt as AI and automation transform the laboratory (Photo courtesy of Shutterstock)

WHX Labs in Dubai spotlights leadership skills shaping next-generation laboratories

WHX Labs in Dubai (formerly Medlab Middle East), held at Dubai World Trade Centre (DWTC) from 10–13 February, brings together international experts to discuss the factors redefining laboratory leadership,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.